NX Prenatal has filed a notice of an exempt offering of securities to raise $15 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, NX Prenatal is raising $15,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Brian Brohman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About NX Prenatal
Innovations to detect, monitor, & manage pregnancy complications such as Preterm Birth, Preeclampsia & Placenta Accreta. NX Prenatal Inc. is a medical devices company based out of 515 W. Market St, 5th Floor Louisville, Kentucky, United States.
To learn more about NX Prenatal, visit http://www.nxprenatal.com/
Contact:
Brian Brohman, Chief Executive Officer
502-893-4570
https://www.linkedin.com/in/brian-brohman-b8695912/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.